AM, V., DR, S., EES, B., M, M., Z, X., JH, S., . . . DH, R. (2026). Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism. Molecular oncology, 20(2), 307. https://doi.org/10.1002/1878-0261.70128
Chicago Style (17th ed.) CitationAM, Vaquié, et al. "Adaptaquin Is Selectively Toxic to Glioma Stem Cells Through Disruption of Iron and Cholesterol Metabolism." Molecular Oncology 20, no. 2 (2026): 307. https://doi.org/10.1002/1878-0261.70128.
MLA (9th ed.) CitationAM, Vaquié, et al. "Adaptaquin Is Selectively Toxic to Glioma Stem Cells Through Disruption of Iron and Cholesterol Metabolism." Molecular Oncology, vol. 20, no. 2, 2026, p. 307, https://doi.org/10.1002/1878-0261.70128.
Warning: These citations may not always be 100% accurate.
